论文部分内容阅读
目的:分析研究心源性脑栓塞患者采用注射用尿激酶的效果。方法:对我院收治的90例心源性脑梗塞患者的临床资料进行分析研究,随机分为两组,对照组45例常规方法治疗,观察组45例患者在常规治疗基础上结合尿激酶溶栓治疗,对比不同方法疗效。结果:观察组患者的治疗有效率优于对照组,治疗第1天、3天、5天、7天的神经功能缺损评分与治疗对比,差异具有统计学意义(P<0.05)。结论:心源性栓塞患者注射用尿激酶治疗,可有效改善患者的栓塞症状,提高患者的生命质量。
OBJECTIVE: To analyze the effect of urokinase for injection in patients with cardiogenic cerebral embolism. Methods: The clinical data of 90 patients with cardiogenic cerebral infarction admitted to our hospital were analyzed and divided into two groups randomly. The control group received 45 cases of conventional treatment. The observation group of 45 patients combined with urokinase Suppository treatment, the efficacy of different methods. Results: The effective rate of treatment in observation group was better than that in control group. The difference of neurological deficit score and treatment on the 1st, 3rd, 5th and 7th day of treatment was statistically significant (P <0.05). Conclusions: Urokinase therapy in patients with cardioembolism can effectively improve the embolic symptoms and improve the quality of life of patients.